203
Views
10
CrossRef citations to date
0
Altmetric
Research Articles

Power of Automated Algorithms for Combining Time-Line Follow-Back and Urine Drug Screening Test Results in Stimulant-Abuse Clinical Trials

, Ph.D., , Ph.D., , Ph.D., , M.D., , M.D., Ph.D. & , B.A.
Pages 350-357 | Published online: 22 Aug 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (9)

L.M. Ruglass, A. Shevorykin, Y. Zhao, T.K. Killeen, A.G. Bauer, A.A. Morgan-López, S.E. Back, S. Fitzpatrick, T. López-Castro, S.B. Norman, L.M. Saavedra & D.A. Hien. (2023) Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics. Drug and Alcohol Dependence 244, pages 109769.
Crossref
Chad D. Rethorst, Steven S. Henley, Thomas J. Carmody, Adriane dela Cruz, Tracy L. Greer, Robrina Walker, Mark Stoutenberg & Madhukar H. Trivedi. (2021) Moderators of treatment response to exercise in participants with stimulant use disorder: Exploratory results from the Stimulant Reduction using Dosed Exercise (STRIDE)CTN-0037 study. Mental Health and Physical Activity 21, pages 100421.
Crossref
Denise C. Vidot, Chad D. Rethorst, Tom J. Carmody, Mark Stoutenberg, Robrina Walker, Tracy L. Greer & Madhukar H. Trivedi. (2019) Acute and long-term cannabis use among stimulant users: Results from CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) Randomized Control Trial. Drug and Alcohol Dependence 200, pages 139-144.
Crossref
Thomas Carmody, Tracy L. Greer, Robrina Walker, Chad D. Rethorst & Madhukar H. Trivedi. (2018) A complier average causal effect analysis of the Stimulant Reduction Intervention using dosed exercise study. Contemporary Clinical Trials Communications 10, pages 1-8.
Crossref
Joseph M. Trombello, Thomas Carmody, Tracy L. Greer, Robrina Walker, Chad D. Rethorst & Madhukar H. Trivedi. (2017) Psychosocial relationship status and quality as predictors of exercise intervention adherence and substance use outcomes: Results from the STRIDE (CTN-0037) study. Psychiatry Research 254, pages 332-339.
Crossref
Walter Ling, Maureen P. Hillhouse, Andrew J. Saxon, Larissa J. Mooney, Christie M. Thomas, Alfonso Ang, Abigail G. Matthews, Albert Hasson, Jeffrey Annon, Steve Sparenborg, David S. Liu, Jennifer McCormack, Sarah Church, William Swafford, Karen Drexler, Carolyn Schuman, Stephen Ross, Katharina Wiest, P. Todd Korthuis, William Lawson, Gregory S. Brigham, Patricia C. Knox, Michael Dawes & John Rotrosen. (2016) Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study. Addiction 111:8, pages 1416-1427.
Crossref
Brian D. Kiluk, Kathleen M. Carroll, Amy Duhig, Daniel E. Falk, Kyle Kampman, Shengan Lai, Raye Z. Litten, David J. McCann, Ivan D. Montoya, Kenzie L. Preston, Phil Skolnick, Constance Weisner, George Woody, Redonna Chandler, Michael J. Detke, Kelly Dunn, Robert H. Dworkin, Joanne Fertig, Jennifer Gewandter, F. Gerard Moeller, Tatiana Ramey, Megan Ryan, Kenneth Silverman & Eric C. Strain. (2016) Measures of outcome for stimulant trials: ACTTION recommendations and research agenda. Drug and Alcohol Dependence 158, pages 1-7.
Crossref
Larissa J. Mooney, Suzanne Nielsen, Andrew Saxon, Maureen Hillhouse, Christie Thomas, Albert Hasson, Don Stablein, Jennifer McCormack, Robert Lindblad & Walter Ling. (2013) Cocaine Use Reduction with Buprenorphine (CURB): Rationale, design, and methodology. Contemporary Clinical Trials 34:2, pages 196-204.
Crossref
Madhukar H Trivedi, Tracy L Greer, Bruce D Grannemann, Timothy S Church, Eugene Somoza, Steven N Blair, Jose Szapocznik, Mark Stoutenberg, Chad Rethorst, Diane Warden, Kolette M Ring, Robrina Walker, David W Morris, Andrzej S Kosinski, Tiffany Kyle, Bess Marcus, Becca Crowell, Neal Oden & Edward Nunes. (2011) Stimulant Reduction Intervention using Dosed Exercise (STRIDE) - CTN 0037: Study protocol for a randomized controlled trial. Trials 12:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.